4.9 (247) In stock
PDF) Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression, BMC Cancer
PDF) Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment
BCDB - A database for breast cancer research and information. - Abstract - Europe PMC
GABC: A comprehensive resource and Genome Atlas for Breast Cancer - Zhang - 2021 - International Journal of Cancer - Wiley Online Library
PDF) A Novel Prognostic Nomogram for 2-Year Survival in HER2-Positive Breast Cancer Patients
Frontiers Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients
Breast Cancer and Next-Generation Sequencing: Towards Clinical Relevance and Future
Cancers, Free Full-Text
Frontiers A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age, Journal of Translational Medicine
PDF) Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score
PDF) Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients
Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China
Frontiers Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients
